# Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005

> **NCT00161811** · PHASE2,PHASE3 · COMPLETED · sponsor: **Alachua Government Services, Inc.** · enrollment: 1400 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Vero Cell-derived Influenza Vaccine
- **BIOLOGICAL:** Egg cell-derived Influenza Vaccine

## Key facts

- **NCT ID:** NCT00161811
- **Lead sponsor:** Alachua Government Services, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 1400 (—)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00161811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00161811, "Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00161811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*